Literature DB >> 3462466

Methotrexate infusions in poor prognosis acute lymphoblastic leukemia: II. High-dose methotrexate (HDM) in acute lymphoblastic leukemia in childhood: a pilot study from April 1981.

P J Moe, F Wesenberg, S Kolmannskog.   

Abstract

The pilot study using HDM in all cases of ALL in childhood had been run for 4 1/2 years as of September 1985. Fourteen (23%) of all 62 diagnosed cases of ALL had WBC above 50 X 10(9)/L, all 14 achieved CR. Three of them were below one year of age, two also had WBC above 400 X 10(9)/L, the third infant had B-cell-leukemia. The remaining 11 children received our new HDM protocol (Fig. 1), one of them had relapsed (BM) as of September 1985.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3462466     DOI: 10.1002/mpo.2950140316

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  3 in total

1.  Prolonged intrathecal chemotherapy replacing cranial irradiation in high-risk acute lymphatic leukaemia: long-term follow up with cerebral computed tomography scans and endocrinological studies.

Authors:  H Hasle; J Helgestad; J K Christensen; B B Jacobsen; J Kamper
Journal:  Eur J Pediatr       Date:  1995-01       Impact factor: 3.183

2.  Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study.

Authors:  A Desjonquères; P Chevallier; X Thomas; F Huguet; T Leguay; M Bernard; J-O Bay; E Tavernier; A Charbonnier; F Isnard; M Hunault; P Turlure; M Renaud; J-N Bastié; C Himberlin; S Lepretre; B Lioure; V Lhéritier; V Asnafi; K Beldjord; M Lafage-Pochitaloff; M C Béné; N Ifrah; H Dombret
Journal:  Blood Cancer J       Date:  2016-12-09       Impact factor: 11.037

3.  Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001.

Authors:  C Mitchell; S Richards; C J Harrison; T Eden
Journal:  Leukemia       Date:  2009-12-10       Impact factor: 11.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.